Long time response with chemotherapy in ROS1 NSCLC patient with unusual metastatic site

During the last decade the therapeutic landscape of Non Small Cell Lung Cancer (NSCLC) has profoundly changed with the identification of actionable genetic alterations that defined molecularly selected subgroups of patients with specific clinic-pathological characteristics and increased sensitivity...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Biol Ther
Autori principali: Franchina, Tindara, Russo, Alessandro, Ricciardi, Giuseppina Rosaria, Liguori, Giuseppina, Herberg, Astrid, Normanno, Nicola, Adamo, Vincenzo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2016
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5079394/
https://ncbi.nlm.nih.gov/pubmed/27611848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2016.1219822
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi